Compound Profile Scientific & Efficacy Data C 35 H 48 N 10 O 15 Molecular Formula 848.81 g/mol Molecular Weight 7-8 minutes (but effects last many hours due to downstream signaling) Half-Life Variable
Semaglutide is framed as a GLP-1 analog research material, while Tirzepatide is organized as a dual-pathway incretin research compound
Dull, uneven, or pigmented skin doesnt need to be permanent
On 16 April 2026 the FDA removed BPC-157 and 11 other peptides from Category 2, and a Pharmacy Compounding Advisory Committee (PCAC) hearing on 23 and 24 July 2026 is now reviewing whether to add BPC-157, alongside TB-500, KPV, MOTS-C, DSIP, Semax and Epitalon, to the 503A "positive bulks list" (see our FDA PCAC July 2026 explainer)
Never share needles, syringes, or multi-dose vials with another person